Lipella Pharmaceuticals to Publish Abstract Detailing Compelling Preclinical Support for New Product Candidate at ASCO 2024

PITTSBURGH, April 05, 2024 (GLOBE NEWSWIRE) -- Lipella Pharmaceuticals Inc. LIPO ("Lipella," "our", "us" or the "Company"), a clinical-stage biotechnology company addressing serious diseases with significant unmet need, today announces that its abstract has been accepted for the 2024 American…#pittsburgh #lipella #illinois #jonathankaufman #lp50 #nmibc #asco

Source: Reuters: Health - April 5, 2024 Category: Consumer Health News Source Type: news